Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1972 1
1979 1
1991 2
1992 3
1993 1
1994 1
1998 1
2010 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study.
Van Cutsem E, Valderrama A, Bang YJ, Fuchs CS, Shitara K, Janjigian YY, Qin S, Larson TG, Shankaran V, Stein S, Norquist JM, Kher U, Shah S, Alsina M. Van Cutsem E, et al. Among authors: larson tg. ESMO Open. 2021 Aug;6(4):100189. doi: 10.1016/j.esmoop.2021.100189. Epub 2021 Aug 7. ESMO Open. 2021. PMID: 34371381 Free PMC article. Clinical Trial.
A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer.
Haura EB, Ricart AD, Larson TG, Stella PJ, Bazhenova L, Miller VA, Cohen RB, Eisenberg PD, Selaru P, Wilner KD, Gadgeel SM. Haura EB, et al. Among authors: larson tg. Clin Cancer Res. 2010 Apr 15;16(8):2450-7. doi: 10.1158/1078-0432.CCR-09-1920. Epub 2010 Mar 23. Clin Cancer Res. 2010. PMID: 20332327 Free article. Clinical Trial.
Alcoholism and drugs. Addiction.
Larson TG. Larson TG. Minn Med. 1972 Dec;55(12):1144-6. Minn Med. 1972. PMID: 4669992 No abstract available.
13 results